Catalyst Wire Dossier Catalyst Wire Dossier

Ramosetron

ramosetron
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Ramosetron, covering 2009-12-31 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence [Phase 2, Phase 3]

See pricing